Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS).

British journal of cancer·2026
Same author

Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer.

NPJ breast cancer·2025
Same author

Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

The British journal of surgery·2025
Same author

A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatment.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?

Breast (Edinburgh, Scotland)·2025
Same author

Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial.

International journal of radiation oncology, biology, physics·2025

相关实验视频

Updated: Jun 21, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

胃癌 胃癌是指胃癌.

Henk H Hartgrink1, Edwin P M Jansen, Nicole C T van Grieken

  • 1Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

Lancet (London, England)
|July 24, 2009
PubMed
概括

预防胃癌和个性化治疗是降低死亡率的关键. 策略涉及Helicobacter pylori和基因变异等危险因素,以及最新的手术和化疗方法.

科学领域:

  • 在瘤学瘤学.
  • 胃肠病学 胃肠病学
  • 公共卫生 公共卫生

背景情况:

  • 胃癌是全球癌症死亡的主要原因,地理发生率差异很大.
  • 目前的治疗方式,包括手术,在改善晚期的生存和局部区域控制方面存在局限性.
  • 个性化治疗和预防策略对于降低胃癌死亡率至关重要.

研究的目的:

  • 为提供胃癌发病率,原因和病理学的最新概述.
  • 审查胃癌的当前和新型治疗策略,包括手术技术和新辅助/辅助疗法.
  • 探索病例负载对患者结果的影响以及基因签名在治疗中的潜力.

主要方法:

  • 关于胃癌流行病学,风险因素和治疗结果的当前文献的综述.
  • 分析既定和新兴的治疗方法,如微创手术,化疗,放射治疗和向基因疗法.
  • 检查影响患者结果的因素,包括专门的癌症中心的作用.

主要成果:

  • 胃癌发病率在地理位置上有所不同,因此需要根据Helicobacter pylori,宿主遗传学,前体病变和环境因素制定量身定制的预防策略.
  • 虽然手术是基石,但它对晚期疾病的疗效是有限的;最小侵入性技术适用于早期阶段.
  • 涉及新辅助/辅助疗法,基因特征和病例负载影响的新策略显示出改善患者结果的希望.

更多相关视频

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

相关实验视频

Last Updated: Jun 21, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

结论:

  • 有效的胃癌管理需要一个多方面的方法,结合个性化的预防和先进的治疗策略.
  • 对基因特征和治疗量影响的进一步研究对于优化患者生存和生活质量至关重要.
  • 整合新的治疗方法和了解风险概况对于减少胃癌的全球负担至关重要.